SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Koh Mickey B. C.)
 

Search: WFRF:(Koh Mickey B. C.) > Second allogeneic s...

  • Cesaro, SimoneAzienda Osped Univ Integrata, Paediat Haematol & Oncol, Verona, Italy. (author)

Second allogeneic stem cell transplant for aplastic anaemia : a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • 2015-08-25
  • Wiley,2015
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-268411
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-268411URI
  • https://doi.org/10.1111/bjh.13650DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • We analysed the outcome of a second allogeneic haematopoietic stem cell transplant (alloHSCT) in 162 patients reported to the European Society for Blood and Marrow Transplantation between 1998 and 2009. Donor origin was a sibling in 110 and an unrelated donor in 52 transplants, respectively. The stem cell source was bone marrow in 31% and peripheral blood in 69% of transplants. The same donor as for the first alloHSCT was used in 81% of transplants whereas a change in the choice of stem cell source was reported in 56% of patients, mainly from bone marrow to peripheral blood. Neutrophil and platelet engraftment occurred in 85% and 72% of patients, after a median time of 15 and 17days, respectively. Grade II-IV acute graft-versus-host disease (GVHD) and chronic GVHD occurred in 21% and 37% of patients, respectively. Graft failure (GF) occurred in 42 patients (26%). After a median follow-up of 3.5years, the 5-year overall survival (OS) was 60.7%. In multivariate analysis, the only factor significantly associated with a better outcome was a Karnofsky/Lansky score 80 (higher OS). We conclude that a second alloHSCT is feasible rescue option for GF in SAA, with a successful outcome in 60% of cases.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • de latour, Regis PeffaultUniv Paris 07, Dept Haematol, BMT, Hop St Louis, Paris, France. (author)
  • Tridello, GloriaAzienda Osped Univ Integrata, Paediat Haematol & Oncol, Verona, Italy. (author)
  • Pillon, MartaDipartimento Pediat, Clin Oncoematol Pediat, Padua, Italy. (author)
  • Carlson, KristinaUppsala universitet,Hematologi(Swepub:uu)krica965 (author)
  • Fagioli, FrancaRegina Margherita Hosp, Paediat Haematol, Turin, Italy. (author)
  • Jouet, Jean-PierreHop Claude Huriez Serv Malad Sang, Lille, France. (author)
  • Koh, Mickey B. C.St George Hosp, Dept Haematol, London, England. (author)
  • Panizzolo, Irene SaraAzienda Osped Univ Integrata, Paediat Haematol & Oncol, Verona, Italy. (author)
  • Kyrcz-Krzemien, SlawomiraMed Univ Silesia, Univ Dept Haematol, Katowice, Poland.;BMT, Katowice, Poland. (author)
  • Maertens, JohanUniv Hosp Gasthuisberg, Dept Haematol, Leuven, Belgium. (author)
  • Rambaldi, AlessandroOsped Riuniti Bergamo, Div Ematol, Bergamo, Italy. (author)
  • Strahm, BrigitteUniv Med Ctr, Dept Paediat & Adolescent Med, Paediat Haematol & Oncol, Freiburg, Germany. (author)
  • Blaise, DidierInst Paoli Calmettes, Ctr Rech Cancerol Marseille, Programme Transplantat & Therapie Cellulaire, Marseille, France. (author)
  • Maschan, AlexeiFed Res Ctr Paediat Haematol Oncol & Immunol, Moscow, Russia. (author)
  • Marsh, JudithKings Coll London, Kings Coll Hosp, Dept Haematol Med, London, England. (author)
  • Dufour, CarloInst G Gaslini, Paediat Haematol, Genoa, Italy. (author)
  • Azienda Osped Univ Integrata, Paediat Haematol & Oncol, Verona, Italy.Univ Paris 07, Dept Haematol, BMT, Hop St Louis, Paris, France. (creator_code:org_t)

Related titles

  • In:British Journal of Haematology: Wiley171:4, s. 606-6140007-10481365-2141

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view